Assessment of genetic markers for coronary thrombosis: Promise and precaution

Lancet

Volumn 353, Issue 9154, 1999, Pages 687-688

  Ridker, P M ^a   Stampfer, M J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; GLYCOPROTEIN IIIA;

BEHAVIOR; CORONARY ARTERY THROMBOSIS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033608448     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00067-7     Document Type: Note

References (17)

1. D Price P Ridker Factor V Leiden mutation and the risks from thromboembolic disease: a clinical perspective Ann Intern Med 127 1997 895 903
2. JA Kuivenhoven JW Jukema AH Zwinderman The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis N Engl J Med 338 1998 86 93
3. F Cambien O Poirer L Lecerf Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction Nature 359 1992 641 644
4. EJ Weiss PF Bray M Tayback A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis N Engl J Med 334 1996 1090 1094
5. J Holm B Zoller P Svensson E Berntorp L Erhardt B Dahlback Myocardial infarction associated with homozygous resistance to activated protein C Lancet 344 1994 952 953
6. P Frosst HJ Blom R Milos A candidate gentic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 11 13
7. K Lindpaintner MA Pfeffer R Kreutz A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease N Engl J Med 332 1995 706 711
8. A1/A2 polymorphism of platelet glycoprotein IIa and risks of myocardial infarction, stroke, and venous thrombosis Lancet 349 1997 385 388
9. PM Ridker CH Hennekens K Lindpaintner MJ Stampfer PR Eisenberg JP Miletich Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men N Engl J Med 332 1995 912 917
10. P Verhoef EB Rimm DJ Hunter A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among US men J Am Coll Cardiol 32 1998 353 359
11. PM Ridker JP Miletich CH Hennekens JE Buring Ethnic distribution of factor V Leiden in 4047 men and women: implication for venous thromboembolism screening JAMA 277 1997 1305 1307
12. K Moshfegh WA Wuillemin M Redondo Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction Lancet 353 1999 351 354
13. TJ Kunicki M Kritzik DS Annis DJ Nugent Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence Blood 89 1997 1939 1943
14. 33/Pro polymorphism (P1A1/A2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study Thromb Haemost 77 1997 1170 1181
15. A polymorphism in young men with myocardial infarction Lancet 348 1996 485 488
16. A polymorphism of glycoprotein IIb/IIa and the fibrinogen beta 448 polymorphism with myocardial infarction and extent of coronary artery disease Circulation 96 1997 1424 1431
17. DH Walter V Schaechinger VI Elsner S Dimmeler AM Zeiher Platelet glycoprotein IIIa polymorphism and risk of coronary stent thrombosis Lancet 350 1997 1217 1219